Experimental drug targets deadly brain metastases in cancer patients
NCT ID NCT05305365
Summary
This study is testing whether an investigational drug called QBS72S can shrink tumors that have spread to the brain from breast or lung cancer. It involves 21 adults with advanced cancer that has spread to the central nervous system. Researchers will measure how well the drug works by looking at tumor response, how long patients live without their cancer getting worse, and overall survival, while also checking for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford Cancer Institute
Palo Alto, California, 94305, United States
Conditions
Explore the condition pages connected to this study.